» Articles » PMID: 38495077

The Role of Proteinaceous Toxins Secreted by in Interbacterial Competition

Overview
Journal FEMS Microbes
Specialty Microbiology
Date 2024 Mar 18
PMID 38495077
Authors
Affiliations
Soon will be listed here.
Abstract

is highly adapted to colonization of the mammalian host. In humans the primary site of colonization is the epithelium of the nasal cavity. A major barrier to colonization is the resident microbiota, which have mechanisms to exclude . As such, has evolved mechanisms to compete with other bacteria, one of which is through secretion of proteinaceous toxins. strains collectively produce a number of well-characterized Class I, II, and IV bacteriocins as well as several bacteriocin-like substances, about which less is known. These bacteriocins have potent antibacterial activity against several Gram-positive organisms, with some also active against Gram-negative species. bacteriocins characterized to date are sporadically produced, and often encoded on plasmids. More recently the type VII secretion system (T7SS) of has also been shown to play a role in interbacterial competition. The T7SS is encoded by all isolates and so may represent a more widespread mechanism of competition used by this species. T7SS antagonism is mediated by the secretion of large protein toxins, three of which have been characterized to date: a nuclease toxin, EsaD; a membrane depolarizing toxin, TspA; and a phospholipase toxin, TslA. Further study is required to decipher the role that these different types of secreted toxins play in interbacterial competition and colonization of the host.

Citing Articles

Non- Staphylococci Cause the Spontaneous Cure or Persistent Infection of Major Bovine Mastitis Pathogens in the Murine Mammary Glands.

Suriyasathaporn W, Kongkaew A, Intanon M, Srithanasuwan A, Saipinta D, Pangprasit N Animals (Basel). 2024; 14(23).

PMID: 39682491 PMC: 11639905. DOI: 10.3390/ani14233526.


Mutations in the Global Regulator CodY Confer Tolerance to an Interspecies Redox-Active Antimicrobial.

Martini A, Alexander S, Khare A bioRxiv. 2024; .

PMID: 39040146 PMC: 11261909. DOI: 10.1101/2024.07.02.601769.

References
1.
Coelho M, Fleming L, Bastos M . Insights into aureocin A70 regulation: participation of regulator AurR, alternative transcription factor σ(B) and phage ϕ11 regulator cI. Res Microbiol. 2015; 167(2):90-102. DOI: 10.1016/j.resmic.2015.10.004. View

2.
Newstead L, Varjonen K, Nuttall T, Paterson G . Staphylococcal-Produced Bacteriocins and Antimicrobial Peptides: Their Potential as Alternative Treatments for Infections. Antibiotics (Basel). 2020; 9(2). PMC: 7168290. DOI: 10.3390/antibiotics9020040. View

3.
Mafra M, Penido E, Bastos M . Distinct groups of plasmids correlated with bacteriocin production in Staphylococcus aureus. J Gen Microbiol. 1990; 136(8):1591-9. DOI: 10.1099/00221287-136-8-1591. View

4.
Navaratna M, Sahl H, Tagg J . Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol. 1998; 64(12):4803-8. PMC: 90925. DOI: 10.1128/AEM.64.12.4803-4808.1998. View

5.
Thammavongsa V, Kim H, Missiakas D, Schneewind O . Staphylococcal manipulation of host immune responses. Nat Rev Microbiol. 2015; 13(9):529-43. PMC: 4625792. DOI: 10.1038/nrmicro3521. View